KELLEY GREALISH N.P.
Prescription History 1407150451
Nurse Practitioner - Adult Health in Boston, MA

Active since January 05, 2011PECOS EnrolledAccepts Medicare Assignment
55 FRUIT ST, BOSTON, MA 02114(617) 726-2000 Get Directions

NPPES record last updated: January 5, 2011. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KELLEY GREALISH N.P., an active Adult Health specialist practicing in Boston, MA. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 80 documented patient claims. Among these therapy options, the most frequently utilized medication is Lenalidomide, which accounts for 38 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

4
Medications
80
Total Claims
97
30-Day Fills
Lenalidomide
Most Prescribed · 38 claims
View details
4 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by KELLEY GREALISH N.P. in 2024, with prescription volumes, average cost per fill, and MA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other MA PrescribersVs. MA Avg

About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾

It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.

In 2024, this provider wrote 38 Medicare prescriptions for Lenalidomide, about 85% of the volume of the typical Massachusetts prescriber of this medication (44.5). Medicare paid an average of $12,219.19 per fill, versus $12,422.40 statewide.

How often this provider prescribes it

This provider
38
MA average
44.5

This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12,219.19
MA average
$12,422.40

This provider's average cost per fill is below the MA average for this medication.

38
30-Day Fills
standardized to 30-day supplies
1,064
Days of Medication
total across all patients in 2024

About Pomalyst: Pomalidomide is used to treat certain types of cancers (such as multiple myeloma, Kaposi sarcoma). Show more ▾

It works by slowing or stopping the growth of cancer cells. An immunomodulator with antineoplastic and angiogenesis inhibitor activity.

In 2024, this provider wrote 16 Medicare prescriptions for Pomalyst, about half the volume of the typical Massachusetts prescriber of this medication (32.7). Medicare paid an average of $20,153.84 per fill, versus $20,913.83 statewide.

How often this provider prescribes it

This provider
16
MA average
32.7

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$20,153.84
MA average
$20,913.83

This provider's average cost per fill is below the MA average for this medication.

16
30-Day Fills
standardized to 30-day supplies
448
Days of Medication
total across all patients in 2024

About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾

It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.

In 2024, this provider wrote 14 Medicare prescriptions for Revlimid, about a third of the volume of the typical Massachusetts prescriber of this medication (38.2). Medicare paid an average of $18,365.71 per fill, versus $16,890.78 statewide.

How often this provider prescribes it

This provider
14
MA average
38.2

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$18,365.71
MA average
$16,890.78

Gross Part D cost per fill; not the patient's out-of-pocket price.

14
30-Day Fills
standardized to 30-day supplies
392
Days of Medication
total across all patients in 2024

About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾

It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes.

In 2024, this provider wrote 12 Medicare prescriptions for Acyclovir, about half the volume of the typical Massachusetts prescriber of this medication (28). Medicare paid an average of $19.26 per fill, versus $17.16 statewide.

How often this provider prescribes it

This provider
12
MA average
28.0

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$19.26
MA average
$17.16

Gross Part D cost per fill; not the patient's out-of-pocket price.

29
30-Day Fills
standardized to 30-day supplies
870
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average MA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MA average cost per fill.

About this data. The prescription history for KELLEY GREALISH N.P. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Adult Health prescribing approach at this Boston, MA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.